The efficacy of reducing agents or antioxidants in blocking the formation of dense cells and irreversibly sickled cells in vitro
- PMID: 9596687
The efficacy of reducing agents or antioxidants in blocking the formation of dense cells and irreversibly sickled cells in vitro
Abstract
We show that N-acetylcysteine (NAC) has the ability to cause statistically significant diminishment in the in vitro formation of irreversibly sickled cells (ISCs) at concentrations greater than 250 micromol/L. Other antioxidants, approved for human use (cysteamine, succimer, dimercaprol), were not efficacious. NAC had the ability to cause statistically significant conversion of ISCs formed in vivo back to the biconcave shape. NAC was also shown to reduce the formation of dense cells and increase the available thiols in beta-actin. We showed that diminishing reduced glutathione (GSH), by treatment with 1-chloro-2,4-dinitrobenzene, resulted in increased dense cells. We conclude the NAC blocks dense cell formation and ISC formation by targeting channels involved in cellular dehydration and beta-actin, respectively. The efficacy of NAC is probably due to its combined antioxidant activity and ability to increase intracellular GSH.
Similar articles
-
The irreversibly sickled cell: a perspective.Cell Mol Biol (Noisy-le-grand). 2004 Feb;50(1):53-8. Cell Mol Biol (Noisy-le-grand). 2004. PMID: 15040427 Review.
-
Effects of N-acetylcysteine on dense cell formation in sickle cell disease.Am J Hematol. 2003 May;73(1):26-32. doi: 10.1002/ajh.10321. Am J Hematol. 2003. PMID: 12701116 Clinical Trial.
-
N-acetylcysteine and clotrimazole inhibit sickle erythrocyte dehydration induced by 1-chloro-2,4-dinitrobenzene.Am J Hematol. 1999 Sep;62(1):19-24. doi: 10.1002/(sici)1096-8652(199909)62:1<19::aid-ajh4>3.0.co;2-c. Am J Hematol. 1999. PMID: 10467272
-
Formation of light irreversibly sickled cells during deoxygenation-oxygenation cycles.J Lab Clin Med. 1987 Nov;110(5):653-60. J Lab Clin Med. 1987. PMID: 3668362
-
N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why.Free Radic Res. 2018 Jul;52(7):751-762. doi: 10.1080/10715762.2018.1468564. Epub 2018 May 9. Free Radic Res. 2018. PMID: 29742938 Review.
Cited by
-
Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy.Hematol Rep. 2010 Jan 26;2(1):e2. doi: 10.4081/hr.2010.e2. Epub 2010 Apr 13. Hematol Rep. 2010. PMID: 22184515 Free PMC article.
-
Safety assessment of rice bran oil in a chicken embryo model.Avicenna J Phytomed. 2016 May-Jun;6(3):351-6. Avicenna J Phytomed. 2016. PMID: 27462559 Free PMC article.
-
Pathophysiology and recent therapeutic insights of sickle cell disease.Ann Hematol. 2020 May;99(5):925-935. doi: 10.1007/s00277-020-03977-9. Epub 2020 Mar 10. Ann Hematol. 2020. PMID: 32157419 Review.
-
Effect of 1-chloro-2,4-dinitrobenzene on K+ transport in normal and sickle human red blood cells.J Physiol. 2003 Mar 15;547(Pt 3):903-11. doi: 10.1113/jphysiol.2002.036467. Epub 2003 Feb 7. J Physiol. 2003. PMID: 12576491 Free PMC article.
-
The Effect of Antioxidants on the Properties of Red Blood Cells From Patients With Sickle Cell Anemia.Front Physiol. 2019 Aug 13;10:976. doi: 10.3389/fphys.2019.00976. eCollection 2019. Front Physiol. 2019. PMID: 31456691 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical